This protocol is judged by an institutional assessment board, an unbiased team that evaluations any scientific trials involving people. If a review entails a Program I drug, once the board approves the protocol as moral, the researchers must make an application for an investigational new drug (IND) selection from the FDA.Subsequently, prescription